Form D/A - Notice of Exempt Offering of Securities: [Amend]
SEC Accession No. 0001662244-16-000003
Filing Date
2016-11-16
Accepted
2016-11-16 11:26:37
Documents
1
Effectiveness Date
2016-11-16
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D/A  
1 primary_doc.xml D/A 9189
  Complete submission text file 0001662244-16-000003.txt   10214
Mailing Address 763E CONCORD AVENUE CAMBRIDGE MA 02138
Business Address 763E CONCORD AVENUE CAMBRIDGE MA 02138 617-248-5239
Cyteir Therapeutics, Inc. (Filer) CIK: 0001662244 (see all company filings)

EIN.: 455429901 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D/A | Act: 33 | File No.: 021-254143 | Film No.: 162001716